Stock Market News 9 December 2025

Home Depot (HD) Stock on December 9, 2025: Investor Day Guidance, 2026 Outlook, and What It Means for Shareholders

Home Depot, Inc. (NYSE: HD) is in the spotlight today as management hosts its 2025 Investor & Analyst Conference in Atlanta, reaffirming 2025 guidance while laying out a cautious, below-consensus outlook for 2026. That mix of steady near‑term performance and tempered expectations for next year is driving trading in Home Depot stock and reshaping Wall Street forecasts. As of around 15:00 UTC on December 9, 2025, HD shares were trading near $355.13, up about 1.5% on the day after earlier weakness, but still roughly 10% lower year-to-date, versus a roughly 16% gain for the S&P 500 over the same period.

9 December 2025

Stock Market

PepsiCo Stock Today: Elliott Deal, 2026 Outlook and Analyst Targets for PEP (December 9, 2025)

PepsiCo, Inc. (NASDAQ: PEP) is back in the spotlight after striking a wide‑ranging pact with activist investor Elliott Investment Management, unveiling a sweeping cost‑cutting and product‑simplification plan, and issuing a preliminary financial outlook for 2026. At the same time, Wall Street analysts are nudging price targets higher while remaining cautious on near‑term growth. As of mid‑afternoon U.S. trading on December 9, 2025, PepsiCo shares were changing hands around $145–$146, roughly flat on the day and modestly below recent intraday highs near $147. Here’s what today’s investors need to know about the new strategy, the 2025–2026 forecast, and how analysts now

9 December 2025

NASDAQ:PEP·Stock Market

Ares Management (ARES) Soars on S&P 500 Inclusion: Latest News, Analyst Forecasts and What’s Next for the Stock

Published: December 9, 2025 – All data as of intraday U.S. trading on this date. This article is for information only and is not investment advice. Ares Management Stock Today: S&P 500 News Sparks a Big Rally Ares Management Corporation (NYSE: ARES) is having a breakout session on December 9, 2025. The driver is clear: Ares is joining the S&P 500 index, replacing Kellanova (the company behind brands like Pringles and Pop‑Tarts), which is being acquired by Mars in a $36 billion deal. News Release Archive+1 This move instantly elevates Ares into the U.S. large‑cap mainstream, alongside alternative‑asset peers Blackstone,

9 December 2025

NYSE:ARES·S&P 500·Stock Market

Omnicell (OMCL) Stock Today: Titan XT Launch, New $50 Price Target and What It Means for 2025 Investors

Omnicell, Inc. (NASDAQ: OMCL) is back on traders’ radar after a cluster of positive catalysts in late 2025 – a new flagship product, raised full-year guidance, improving technical momentum, and fresh analyst upgrades. As of the afternoon session on December 9, 2025, Omnicell shares trade around $43.98, giving the company a market capitalization of roughly $1.4 billion and a price-to-earnings ratio just above 70 based on trailing earnings. The stock closed at $43.55 on December 8, capping a multi-month rebound from the high-20s in October. ir.omnicell.com Below is a structured look at the latest news, forecasts, and analysis that matter

9 December 2025

NASDAQ:OMCL·Stock Market

IMAX Stock Soars on Analyst Upgrades and China Growth: What December 2025’s Rally Really Means

As of December 9, 2025, IMAX Corporation (NYSE: IMAX) is trading around $38.28, just below its recent close of $38.50 and near a fresh 52-week high in the high-$37 to $38 range.StockAnalysis+1 The stock has delivered a strong mid-30%–plus total return over the past year and nearly 30% over the last six months, dramatically outpacing the broader market.Investing.com Australia Behind that rally: record box office, a deepening partnership in China, a generous buyback program, and a wave of bullish analyst calls in the last few days. IMAX stock today: rally fueled by upgrades and China headlines IMAX shares have been

9 December 2025

China Economy·NYSE:IMAX·Stock Market

Top US Stock Market Losers Today (December 9, 2025): HURA, Phreesia, Virgin Galactic, SLM, Gogo and More

The US stock market spent most of Tuesday, December 9, 2025 trading quietly ahead of this week’s Federal Reserve decision — but beneath the calm index surface, several individual stocks suffered brutal double‑digit losses. As of around 3:44 p.m. ET, live data from Public.com showed TuHURA Biosciences (HURA), Phreesia (PHR), Euda Health (EUDA), SLM Corp (SLM), Virgin Galactic (SPCE), Gogo (GOGO), Compass Minerals (CMP), Workhorse Group (WKHS), 3D Systems (DDD) and Dyne Therapeutics (DYN) among the steepest percentage decliners across US‑listed stocks. Public Below is a detailed look at what drove today’s biggest losers — and what analysts and companies

9 December 2025

NASDAQ:DYN·NASDAQ:EUDA·NASDAQ:GOGO·NASDAQ:WKHS·NYSE:CMP·NYSE:DDD·NYSE:PHR·NYSE:SLM·NYSE:SPCE·Stock Market·US Stocks

Top Gainers on the US Stock Market Today (December 9, 2025): AFJK, NCPL, XCUR, ALEX and More Surge as Fed Meeting Looms

US stocks spent Tuesday in a cautious, sideways mood as traders waited for the Federal Reserve’s final interest‑rate decision of 2025. The Dow inched higher, the S&P 500 was roughly flat, and the Nasdaq drifted slightly lower, even as expectations hardened around another rate cut and a closely watched press conference from Fed Chair Jerome Powell. Investopedia+3StockAnalysis+3Yahoo Finance+3 Beneath the calm surface of the major indices, however, a cluster of small‑ and mid‑cap names exploded higher, posting double‑ and even triple‑digit gains on deal news, biotech data, SPAC extensions, and debt‑restructuring headlines. Today’s Top 20 US Stock Market Gainers (Intraday,

9 December 2025

Stock Market·US Economy

Canada Stock Market Today, December 9, 2025: TSX Climbs as Gold Stocks Rally Ahead of Fed and Bank of Canada Decisions

Toronto’s S&P/TSX Composite Index finished higher on Tuesday, December 9, 2025, as gold miners, utilities and heavyweight financials led gains while investors braced for back‑to‑back interest‑rate decisions from the U.S. Federal Reserve and the Bank of Canada on Wednesday. According to daily data from Investing.com, the S&P/TSX Composite Index closed at 31,328.16, up around 158 pointsfrom Monday’s close of 31,169.97 — a gain of roughly 0.5% on the day. The benchmark traded between 31,160.89 and 31,340.32 after opening at 31,164.86, with volume just over 37 million shares. Investing.com The index is now hovering just below its recent record high near 31,541, set last week, and has rallied more than 26% year‑to‑date, outpacing major U.S. indices

9 December 2025

Stock Market·TSX·TSX:BAM·TSX:ET·TSX:MFC·TSX:SHOP·TSX:TA

US Stock Market Today, December 9, 2025: Wall Street Pauses as Fed Rate Cut Decision Nears

Wall Street is in “wait-and-see” mode on Tuesday, December 9, 2025, with major US stock indices trading in a tight range as the Federal Reserve begins its final policy meeting of the year and investors digest fresh labor market data and big corporate headlines. By late morning in New York, the Dow Jones Industrial Average and S&P 500 were modestly higher, while the Nasdaq Composite hovered slightly in the red, leaving all three benchmarks still close to record territory after Monday’s small pullback. Reuters+2Investopedia+2 Market Snapshot: Dow Edges Up, Nasdaq Slips US stock futures were slightly positive earlier in the day, with S&P 500 contracts up about 0.1%, signaling

9 December 2025

Federal Reserve·Stock Market

Dyne Therapeutics (DYN) Stock Slides After $300 Million Offering as Duchenne Trial Data Drives Bullish Street Targets

December 9, 2025 — Dyne Therapeutics, Inc. (NASDAQ: DYN) shares were volatile on Tuesday, giving back part of a recent rally even as Wall Street responded positively to new clinical data and raised price targets on the neuromuscular‑disease biotech. In early afternoon U.S. trading, Dyne stock was changing hands around $19.15, down roughly 14% on the day after opening near $21.41 and moving in a range between about $19 and $22. The pullback follows a sharp advance on Monday, when the shares jumped high‑single‑digits after the company released detailed positive Phase 1/2 results from its DELIVER trial in Duchenne muscular

9 December 2025

NASDAQ:DYN·Pharmaceutical Industry·Stock Market

Arrowhead Pharmaceuticals (ARWR) Stock Soars on First FDA Approval, Novartis Deal and New Alzheimer’s Trial

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is ending 2025 in rare biotech air. The RNA interference (RNAi) specialist has secured its first U.S. drug approval, locked in a multibillion‑dollar licensing deal with Novartis, and just dosed the first subjects in a new Alzheimer’s disease trial — all while its share price hovers near record highs. Arrowhead Pharmaceuticals, Inc.+2Arrowhead Pharmaceuticals+2 As of intraday trading on December 9, 2025, Arrowhead Pharmaceuticals stock trades around $69 per share, giving the company a market value in the $9–9.5 billion range. That’s up dramatically from under $10 per share at its 52‑week low, and represents a

9 December 2025

NASDAQ:ARWR·Pharmaceuticals·Stock Market

Robinhood (HOOD) Stock Today: Price, Latest News, Crypto Expansion and 2026 Forecasts

As of December 9, 2025, Robinhood Markets, Inc. (NASDAQ: HOOD) is trading around $136 per share, giving the online broker a market capitalization in the $120–$125 billion range and a price-to-earnings ratio near 56–58.MarketBeat The stock has been one of the best-performing names in the S&P 500 in 2025. NerdWallet data shows Robinhood leading the index with a ~240% one‑year return and roughly 243% year‑to‑date gain as of early December, far ahead of other top performers like Western Digital and Palantir.NerdWallet Other analyses put its 2025 gain closer to 260–270%, reflecting continued momentum into December.Ticker Nerd+1 At the same time,

9 December 2025

Cryptocurrency·Stock Market

Previous 1 … 1,400 1,401 1,402 1,403 1,404 … 1,946 Next

Stellantis stock slides 24% after €22 billion EV reset kills 2026 dividend — what to watch next

7 February 2026

Stellantis shares plunged 23.7% to $7.28 Friday after the company disclosed about €22.2 billion in charges tied to a reset of its electric-vehicle strategy and said it will skip its 2026 dividend. The automaker flagged a preliminary net loss of €19–21 billion for the second half of 2025. Shares rose 1.6% in late after-hours trading. Investors await Feb. 26 results and a May 21 Investor Day.

Intel stock jumps on China server CPU delays as traders map the week ahead

7 February 2026

Intel shares rose 4.87% to $50.59 Friday, trailing gains by Nvidia and Broadcom as chip stocks rallied. Sources said Intel and AMD warned Chinese customers of longer waits and higher prices for some server CPUs, with Intel lead times reaching six months. Intel said China accounts for over 20% of its revenue. Investors await key U.S. jobs and inflation data next week.

IRS tax refund delays? Watchdog flags staffing crunch as 2026 filing season ramps up

7 February 2026

IRS staffing has dropped to 2021 levels as the 2026 tax filing season begins, according to a Treasury watchdog. The agency faces a backlog of about 2 million returns, 129% above pre-pandemic levels. Most e-filers using direct deposit still get refunds within 21 days, but paper filings and amended returns could see delays. The IRS lowered its call-answer target to 70% for this season.

Plug Power stock jumps 12% after vote setback, with Feb 17 share decision in focus

7 February 2026

Plug Power shares rose 11.6% Friday to $2.08 after a sharp drop the previous day, as attention shifted to a Feb. 17 shareholder vote on expanding authorized shares. The company failed to secure enough votes earlier this week and is urging overseas holders to participate. CEO Andy Marsh cited difficulties for European investors in casting ballots. A reverse stock split remains possible if the proposal fails.